American Cannabis Operators Decline 18.0% in December

Following a 5.8% decline in its inaugural month, the American Cannabis Operator Index fell 18.0% during December:

During December, the index included 17 companies, including 12 multi-state operators (MSOs) and five focused on CBD extracted from industrial hemp. Several MSOs have a dual strategy that also includes selling CBD across the country, including Curaleaf Holdings (CSE: CURA) (OTC: CURLF), Green Growth Brands (CSE: GGB) (OTC: GGBXF) and 1933 Industries (CSE: TGIF) (OTC: TGIFF).  Only one name managed a positive return, while three lost more than a third of their value:

The passage of the Farm Act, which legalized hemp, helped push Elixinol Global (ASX: EXL) (OTC: ELLXF) to the only gain. Other CBD producers Charlotte’s Web (CSE: CWEB) (OTC: CWBHF) and CV Sciences (OTC: CVSI) declined less than the index as well. The worst performer was Terra Tech (OTC: TRTC), which declined sharply after being sued for alleged fraud, a lawsuit which it said is without merit.

For January, the index will include 18 names, as United Cannabis (OTC: CNAB) no longer qualified due to its trading volume in the United States declining below the minimum while 1933 Industries and Green Growth Brands will now be included.  There are several names that listed on the Canadian Securities Exchange recently that we expect will join in the near future once they obtain actual OTC listings.

In the next monthly review, we will summarize the performance for January and discuss any additions or deletions. Be sure to bookmark the page to stay current on American cannabis operators stock price movements within the day or from day-to-day.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter